In Vitro and In Vivo Activities of Gatifloxacin against Mycobacterium tuberculosis
Gatifloxacin (GAT) and moxifloxacin (MXF) were evaluated in vitro to determine their activities against Mycobacterium tuberculosis. GAT was subsequently compared in a dose range study to isoniazid (INH) in a murine tuberculosis model. GAT was somewhat less active than INH. GAT and MXF were evaluated...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127120/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11897584/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.4.1022-1025.2002 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|